Arcturus Therapeutics Announces Third Quarter 2025 Financial Update and Pipeline Progress Life Science Investing
Mereo BioPharma Reports Third Quarter 2025 Financial Results and Provides Corporate Highlights Biotech Investing
Nextech3D.ai Announces CEO Evan Gappelberg Acquires 550,000 Shares of Company Stock In Open Market Buys Artificial Intelligence Investing
Rakovina Therapeutics to Present New Data Highlighting CNS-Penetrant ATR and PARP1 Inhibitors at the 2025 Society for Neuro-Oncology Annual Meeting Life Science Investing
Senseonics Holdings, Inc. to Participate in the Stifel 2025 Healthcare Conference Life Science Investing
Guardant Health Expands Tissue-Free Reveal Test to Include Late-Stage Therapy Response Monitoring Life Science Investing
HOPE Therapeutics, Inc., an NRx Pharmaceuticals Subsidiary, Announces First-in-Florida Initiation of One Day Depression Treatment in Partnership with Ampa Health Life Science Investing
Nextech3D.ai Announces CEO Evan Gappelberg Acquires 550,000 Shares of Company Stock In Open Market Buys Artificial Intelligence Investing
Galectin Therapeutics Presented NAVIGATE Trial Results at the American Association for the Study of Liver Diseases 2025 Annual Meeting Life Science Investing
